The NHS spending watchdog must look again at its decision after drug manufacturers successfully appealed against Nice's ruling that the treatments were not cost-effective ...

The NHS will reconsider approving two Alzheimer’s “wonder drugs” after a successful appeal. The National Institute of Health ...

A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer’s prevention, a new study suggests. The anti-seizure medication, levetiracetam, was first approved ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Add Yahoo as a preferred source to see more of our stories on Google. Drugs that halt Alzheimer’s should be rolled out more widely, Baroness Casey has said. In her first speech since she was appointed ...

Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than previously believed. The research also found that over one in ten people aged 70 ...

Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering ...

A simple test could detect Alzheimer's years before symptoms appear, offering hope for earlier intervention and treatment.

Researchers have used precision-engineered nanoparticles to restore memory and clear hallmark brain plaques in mouse models of Alzheimer’s disease, a result that is already being described as a ...